A genetically supported drug repurposing pipeline for diabetes treatment using electronic health records

Megan M. Shuey, Kyung Min Lee, Jacob Keaton, Nikhil K. Khankari, Joseph H. Breeyear, Venexia M. Walker, Donald R. Miller, Kent R. Heberer, Peter D. Reaven, Shoa L. Clarke, Jennifer Lee, Julie A. Lynch, Marijana Vujkovic, Todd L. Edwards
doi: https://doi.org/10.1101/2022.12.14.22283414

Article usage

Article usage: December 2022 to June 2025

AbstractFullPdf
Dec 20224431079
Jan 20231021256
Feb 202383635
Mar 202352613
Apr 20233562
May 20231611
Jun 20232077
Jul 20231216
Aug 202321125
Sep 20231544
Oct 20232161
Nov 202323103
Dec 20231513
Jan 20241142
Feb 20241495
Mar 20242562
Apr 20241468
May 20242346
Jun 20241904
Jul 20241739
Aug 20241683
Sep 202414610
Oct 20243021
Nov 20242027
Dec 20241904
Jan 20252055
Feb 202520262
Mar 2025263714
Apr 20252566
May 20251987
Jun 2025220
Back to top
Posted December 16, 2022.
Download PDF

Supplementary Material

Data/Code
Email
A genetically supported drug repurposing pipeline for diabetes treatment using electronic health records
Megan M. Shuey, Kyung Min Lee, Jacob Keaton, Nikhil K. Khankari, Joseph H. Breeyear, Venexia M. Walker, Donald R. Miller, Kent R. Heberer, Peter D. Reaven, Shoa L. Clarke, Jennifer Lee, Julie A. Lynch, Marijana Vujkovic, Todd L. Edwards
medRxiv 2022.12.14.22283414; doi: https://doi.org/10.1101/2022.12.14.22283414
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area